Enfusion, Inc (ENFN) Misses Q2 EPS by 3c

Enfusion, Inc (NYSE: ENFN) reported Q2 EPS of $0.01, $0.03 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $44.59 million.

For earnings history and earnings-related data on Enfusion, Inc (ENFN) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance